Full Text

Turn on search term navigation

© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

The development of new photodynamic therapy (PDT) agents designed for bladder cancer (BC) treatments is of utmost importance to prevent its recurrence and progression towards more invasive forms. Here, three different porphyrinic photosensitizers (PS) (TMPyP, Zn-TMPyP, and P1-C5) were non-covalently loaded onto graphene oxide (GO) or graphene quantum dots (GQDs) in a one-step process. The cytotoxic effects of the free PS and of the corresponding hybrids were compared upon blue (BL) and red-light (RL) exposure on T24 human BC cells. In addition, intracellular reactive oxygen species (ROS) and singlet oxygen generation were measured. TMPyP and Zn-TMPyP showed higher efficiency under BL (IC50: 0.42 and 0.22 μm, respectively), while P1-C5 was more active under RL (IC50: 0.14 μm). In general, these PS could induce apoptotic cell death through lysosomes damage. The in vitro photosensitizing activity of the PS was not compromised after their immobilization onto graphene-based nanomaterials, with Zn-TMPyP@GQDs being the most promising hybrid system under RL (IC50: 0.37 μg/mL). Overall, our data confirm that GO and GQDs may represent valid platforms for PS delivery, without altering their performance for PDT on BC cells.

Details

Title
Graphene Oxide and Graphene Quantum Dots as Delivery Systems of Cationic Porphyrins: Photo-Antiproliferative Activity Evaluation towards T24 Human Bladder Cancer Cells
Author
Menilli, Luca 1   VIAFID ORCID Logo  ; Monteiro, Ana R 2 ; Lazzarotto, Silvia 3 ; Morais, Filipe M P 4 ; Ana T P C Gomes 5   VIAFID ORCID Logo  ; Moura, Nuno M M 4   VIAFID ORCID Logo  ; Fateixa, Sara 6   VIAFID ORCID Logo  ; Faustino, Maria A F 4   VIAFID ORCID Logo  ; Maria G P M S Neves 4   VIAFID ORCID Logo  ; Trindade, Tito 6   VIAFID ORCID Logo  ; Miolo, Giorgia 3   VIAFID ORCID Logo 

 Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35131 Padova, Italy; [email protected] (L.M.); [email protected] (S.L.); Department of Biology, University of Padova, 35131 Padova, Italy 
 CICECO—Aveiro Institute of Materials, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal; [email protected] (A.R.M.); [email protected] (S.F.); LAQV—Requimte, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal; [email protected] (F.M.P.M.); [email protected] (N.M.M.M.); [email protected] (M.A.F.F.) 
 Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35131 Padova, Italy; [email protected] (L.M.); [email protected] (S.L.) 
 LAQV—Requimte, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal; [email protected] (F.M.P.M.); [email protected] (N.M.M.M.); [email protected] (M.A.F.F.) 
 CESAM, Department of Biology, University of Aveiro, 3810-193 Aveiro, Portugal; [email protected]; Center for Interdisciplinary Investigation (CIIS), Faculty of Dental Medicine, Universidade Católica Portuguesa, 3504-505 Viseu, Portugal 
 CICECO—Aveiro Institute of Materials, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal; [email protected] (A.R.M.); [email protected] (S.F.) 
First page
1512
Publication year
2021
Publication date
2021
Publisher
MDPI AG
e-ISSN
19994923
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2576480455
Copyright
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.